Efficacy Evaluation of the Alleviating Effect of Coriander Powder Intake on Nasal Discomfort during Cedar Pollen Dispersion - A Randomized, Double-blind, Placebo-Controlled Parallel Group Comparative Trial
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000053366
- Lead Sponsor
- S&B FOODS INC.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 60
Not provided
1. Those currently receiving medical treatment or treatment with medicines or Kampo for any disease (intermittent use is acceptable). 2. Those with acute rhinitis, sinusitis, nasal polyps, deviated nasal septum, etc.. 3. Those who have undergone nasal cavity surgery. 4. Those with bronchial asthma. 5. Those who have or had serious liver, kidney, heart, respiratory, endocrine, metabolic diseases, etc. (appendicitis is acceptable). 6. Those undergoing specific desensitization therapy. 7. Those who regularly consume lactic acid bacteria products, lactic acid bacteria supplements, and yogurt (3 or more times a week) (those who can suspend consumption during the study period are acceptable). 8. Those who regularly consume foods with anti-allergy effects such as sweet tea and benifuuki tea (3 or more times a week) (those who can suspend consumption during the study period are acceptable). 9. Those who may have allergic symptoms to the research food. 10. Those who consume healthy foods (foods or supplements aimed at maintaining or recovering health) (those who can suspend consumption during the study period are acceptable). 11. Those with a current or past history of drug allergy or food allergy. 12. Those who have participated in other clinical trials within one month before consent acquisition or are currently participating. 13. Those who are currently pregnant or breastfeeding, and those who wish to become pregnant. 14. Those with excessive drinking habits exceeding about 40 g of pure alcohol per day. 15. Those with smoking habits (less than one year after quitting). 16. Those with shift work including night shifts. 17. Those who have experienced discomfort or deterioration of physical condition due to blood collection in the past. 18. Those who may change their lifestyle during the study period, such as long-term travel. 19. Others whom the research physician judges to be inappropriate as subjects of this trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method